SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.

Am J Hematol

Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.

Published: September 2022

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.26648DOI Listing

Publication Analysis

Top Keywords

sf3b1 mutations
4
mutations primary
4
primary secondary
4
secondary myelofibrosis
4
myelofibrosis clinical
4
clinical molecular
4
molecular prognostic
4
prognostic correlates
4
sf3b1
1
primary
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!